🇺🇸 FDA
Pipeline program

No Intervention

Namilumab-1003

Phase 1 other completed

Quick answer

No Intervention for Rheumatoid Arthritis is a Phase 1 program (other) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TAKEDA PHARMACEUTICAL CO LTD
Indication
Rheumatoid Arthritis
Phase
Phase 1
Modality
other
Status
completed

Clinical trials